Clinical Trials Directory

Trials / Completed

CompletedNCT01123837

A Closer Look at the Effect of Dextrose on Postoperative Nausea and Vomiting

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
202 (actual)
Sponsor
Loma Linda University · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

"The purpose of this investigator-initiated study is to see if giving dextrose fluid in the veins (IV) decreases the risk of postoperative nausea and vomiting (PONV) in female urologic, gynecologic and breast outpatient surgery patients and at what blood surgery level. The reason for this study is that IV dextrose has been shown to decrease the incidence of PONV and the use of medications to treat PONV, while leading to sooner discharge after surgery. This can decrease overall healthcare cost and improving patient satisfaction."

Conditions

Interventions

TypeNameDescription
OTHERIntravenous fluidThe treatment group will receive a 250cc bolus over 2 hrs of D5LR prior to the end of surgery and continued in the PACU. Blood glucose will be checked 3 different times using an Accu-chek monitor along with the type and number of rescue medications given at 30, 60, and 120 minutes after anesthesia and the post-op morning. The control group will receive a 250cc bolus over 2 hours of LR. Blood glucose will be monitored 3 times along with the type and how much of rescue medications are given at 30, 60 and 120 minutes post-op and the morning after surgery.
OTHERD5LR or lactated ringersThe purpose of the study is to see if giving dextrose fluid in the veins (IV) decreases the risk of postoperative nausea and vomiting (PONV) in female urologic, gynecologic and breast outpatient surgery patients and at what blood sugar level. The reason for this study is that IV dextrose may decrease the incidence of PONV and the use of medications to treat PONV, while leading to sooner discharge after surgery. This can decrease overall healthcare cost and improving patient satisfaction.

Timeline

Start date
2010-04-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2010-05-14
Last updated
2014-01-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01123837. Inclusion in this directory is not an endorsement.